Our Offering
Biologics
Mammalian
Microbial
ADCs / Bioconjugates
Drug Product
mRNA / LNP
Expression Technologies
Small Molecules
Drug Substance (API)
Particle Engineering
Drug Product
Cell & Gene
Process Development
cGMP manufacturing
Allogeneic
Autologous
Viral Vectors
Bioscience Products
Capsules & Health Ingredients
Pharmaceutical Solutions
Nutraceutical Solutions
Services and Support Solutions
Our Company
About Us
Purpose and Strategy
Leadership
History
Locations
Site Tours
Partnering with Us
Events
News and Media
News Releases
Images and Videos
Logo Guidelines
Blog
Podcast
Journalist Inquiries
Investor Relations
Shareholder Information
Agenda and Events
Reporting and Presentations
Consensus and Analysts
Corporate Governance
Ethics and Compliance
Investor Inquiries
Sustainability
Environment
People and Society
Compliance and Integrity
Responsible Sourcing
Global Quality
Sustainability Report
Careers
Overview
Life at Lonza
What We Offer
Career Stories
Job Search
Join Our Talent Community
Recruitment Process
Students, Graduates and Apprentices
Contact
Our Offering
Corporate
Biologics
Mammalian
Microbial
ADCs / Bioconjugates
Drug Product
mRNA / LNP
Expression Technologies
Small Molecules
Drug Substance (API)
Particle Engineering
Drug Product
Cell & Gene
Process Development
cGMP manufacturing
Allogeneic
Autologous
Viral Vectors
Bioscience Products
Capsules & Health Ingredients
Pharmaceutical Solutions
Nutraceutical Solutions
Services and Support Solutions
Our Company
Corporate
About Us
Purpose and Strategy
Leadership
History
Locations
Site Tours
Partnering with Us
Events
News and Media
News Releases
Images and Videos
Logo Guidelines
Blog
Podcast
Journalist Inquiries
Investor Relations
Shareholder Information
Agenda and Events
Reporting and Presentations
Consensus and Analysts
Corporate Governance
Ethics and Compliance
Investor Inquiries
Sustainability
Environment
People and Society
Compliance and Integrity
Responsible Sourcing
Global Quality
Sustainability Report
Careers
Corporate
Overview
Life at Lonza
What We Offer
Career Stories
Job Search
Join Our Talent Community
Recruitment Process
Students, Graduates and Apprentices
Contact
Corporate
Shareholders and Stock Information
Home
Investor Relations
Shareholders and Stock Information
Major shareholders according to SIX Swiss Exchange Disclosure Office
(as of 10 September 2024)
BlackRock, Inc. – 9.85%
UBS Fund Management (Switzerland) AG – 6.246%
Find historical shareholding disclosures on the
SIX Exchange Regulation website
.
Shareholder resources
Consensus and Analysts
Overview of sell-side analysts that cover Lonza on a regular basis, and our consensus forecasts.
Learn more
Bond Investors and Credit Information
Credit Ratings: View the assessments of Lonza. Information for credit analysts, debt investors and rating agencies.
Learn more
Reporting and Presentations
All Lonza’s financial and non-financial reports, presentations and key company updates available in the Reporting Center.
Learn more
Share Buyback
Overview of Lonza’s current share buyback program.
Learn more
Investor FAQ
Overview of key investor relevant topics addressed by Lonza about its shares, general finance and investor relations services.
Learn more
Previous
Next
Cookie Settings